BENLYSTA
BENLYSTA
Approved
DIN Number
02470489
Drug Class
Human
Market Date
May 14, 2018
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02470489
AIG Number0152941003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AG04 BELIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
BELIMUMABActive
Strength: 200 MG / 1 ML
Monograph: BELIMUMAB